Functional activity of human hepatoma cells transfected with adenovirus-mediated hepatocyte nuclear factor (HNF)-4 gene

Cell Transplantation

Volumn 13, Issue 4, 2004, Pages 393-403

  Naiki, Takafumi ^a   Nagaki, Masahito ^a   Shidoji, Yoshihiro ^b   Kojima, Hisanori ^a   Moriwaki, Hisataka ^a  

^a GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF NAGASAKI   (Japan)

Author keywords

Adenovirus; Bioartificial liver; Fulminant hepatic failure; Hepatocyte nuclear factor 4; Transcription factor

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; AMMONIA; AMMONIUM CHLORIDE; APOLIPOPROTEIN; COMPLEMENTARY DNA; CYTOCHROME P450; GLUTAMATE AMMONIA LIGASE; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP);

ANIMAL CELL; ARTIFICIAL LIVER; BIOARTIFICIAL ORGAN; CELL ACTIVITY; CELL LINE; CELL STRAIN; CELL STRAIN HEPG2; CELL STRAIN HUH 7; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; EMBRYO; GENE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HEPATOMA CELL; HNF 4 GENE; HUMAN; HUMAN CELL; LIVER CELL; LIVER FAILURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

ADENOVIRIDAE; ANIMALIA;

EID: 4444279774     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000004783983855     Document Type: Conference Paper

References (33)

1. Cereghini, S. Liver-enriched transcription factors and hepatocyte differentiation. FASEB J. 10:267-282; 1996.
2. Chen, S. C.; Hewitt, W. R.; Watanabe, F. D.; Eguchi, S.; Kahaku, E.; Middleton, Y.; Rozga, J.; Demetriou, A. A. Clinical experience with a porcine hepatocyte-based liver support system. Int. J. Artif. Organs 19:664-669; 1996.
3. Christa, L.; Simon, M. T.; Flinois, J. P.; Gebhardt, R.; Brechot, C.; Lasserre, C. Overexpression of glutamine synthetase in human primary liver cancer. Gastroenterology 106:1312-1320; 1994.
4. Duncan, S. A.; Manova, K.; Chen, W. S.; Hoodless, P.; Weinstein, D. C.; Bachvarova, R. F.; Darnell, J. E. Expression of transcription factor HNF-4 in the extraembryonic endoderm, gut, and nephrogenic tissue of the developing mouse embryo: HNF-4 is a marker for primary endoderm in the implanting blastocyst. Proc. Natl. Acad. Sci. USA 91:7598-7602; 1994.
5. Dunn, J. C.; Tompkins, R. G.; Yarmush, M. L. Hepatocytes in collagen sandwich: Evidence for transcriptional and translational regulation. J. Cell Biol. 116:1043-1053; 1992.
6. Ellis, A. J.; Hughes, R. D.; Wendon, J. A.; Dunne, J.; Langley, P. G.; Kelly, J. H.; Gislason, G. T.; Sussman, N. L.; Williams, R. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology 24:1446-1451; 1996.
7. Fraser, J. D.; Keller, D.; Martinez, V.; Santiso-Mere, D.; Straney, R.; Briggs, M. R. Utilization of recombinant adenovirus and dominant negative mutants to characterize hepatocyte nuclear factor 4-regulated apolipoprotein Al and CIII expression. J. Biol. Chem. 272:13892-13898; 1997.
8. Hayhurst, G. P.; Lee, Y. H.; Lambert, G.; Ward, J. M.; Gonzalez, F. J. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol. Cell. Biol. 21: 1393-1403; 2001.
9. King, C. D.; Rios, G. R.; Green, M. D.; Tephly, T. R. UDP-glucuronosyltransferases. Curr. Drug Metab. 1:143-161; 2000.
10. Koide, N.; Sakaguchi, K.; Koide, Y.; Asano, K.; Kawaguchi, M.; Matsushima, H.; Takenami, T.; Shinji, T.; Mori, M.; Tsuji, T. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp. Cell Res. 186:227-235; 1990.
11. Kuo, C. J.; Conley, P. B.; Chen, L.; Sladek, F. M.; Darnell, J. E.; Crabtree, G. R. A transcriptional hierarchy involved in mammalian cell-type specification. Nature 355: 457-461; 1992.
12. Lee, W. M. Acute liver failure. N. Engl. J. Med. 329: 1862-1872; 1993.
13. Li, J.; Ning, G.; Duncan, S. A. Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. Genes Dev. 14:464-474; 2000.
14. Miyake, S.; Makimura, M.; Kanegae, Y.; Harada, S.; Sato, Y.; Takamori, K.; Tokuda, C.; Saito, I. Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. Proc. Natl. Acad. Sci. USA 93: 1320-1324; 1996.
15. Nagaki, M.; Miki, K.; Kim, Y. I.; Ishiyama, H.; Hirahara, I.; Takahashi, H.; Sugiyama, A.; Muto, Y.; Moriwaki, H. Development and characterization of a hybrid bioartificial liver using primary hepatocytes entrapped in a basement membrane matrix. Dig. Dis. Sci. 46:1046-1056; 2001.
16. Nagaki, M.; Shidoji, Y.; Yamada, Y.; Sugiyama, A.; Tanaka, M.; Akaike, T.; Ohnishi, H.; Moriwaki, H.; Muto, Y. Regulation of hepatic genes and liver transcription factors in rat hepatocytes by extracellular matrix. Biochem. Biophys. Res. Commun. 210:38-43; 1995.
17. Naiki, T.; Nagaki, M.; Shidoji, Y.; Kojima, H.; Imose, M.; Kato, T.; Ohishi, N.; Yagi, K.; Moriwaki, H. Analysis of gene expression profile induced by hepatocyte nuclear factor 4a in hepatoma cells using an oligonucleotide microarray. J. Biol. Chem. 277:14011-14019; 2002.
18. Nishiwaki, R.; Ohta, T.; Sueoka, E.; Suganuma, M.; Harada, K.; Watanabe, M. F.; Fujiki, H. Two significant aspects of microcystin-LR: Specific binding and liver specificity. Cancer Lett. 83:283-289; 1994.
19. Rozga, J.; Holzman, M. D.; Ro, M. S.; Griffin, D. W.; Neuzil, D. F.; Giorgio, T.; Moscioni, A. D.; Demetriou, A. A. Development of a hybrid bioartificial liver. Ann. Surg. 217:502-509; 1993.
20. Rozga, J.; Podesta, L.; LePage, E.; Morsiani, E.; Moscioni, A. D.; Hoffman, A.; Sher, L.; Villamil, F.; Woolf, G.; McGrath, M.; et al. A bioartificial liver to treat severe acute liver failure. Ann. Surg. 219:538-544; 1994.
21. Rozga, J.; Williams, F.; Ro, M. S.; Neuzil, D. F.; Giorgio, T. D.; Backfisch, G.; Moscioni, A. D.; Hakim, R.; Demetriou, A. A. Development of a bioartificial liver: Properties and function of a hollow-fiber module inoculated with liver cells. Hepatology 17:258-265; 1993.
22. Sheweita, S. A. Drug-metabolizing enzymes: Mechanisms and functions. Curr. Drug Metab. 1:107-132; 2000.
23. Shih, D. Q.; Screenan, S.; Munoz, K. N.; Philipson, L.; Pontoglio, M.; Yaniv, M.; Polonsky, K. S.; Stoffel, M. Loss of HNF-1alpha function in mice leads to abnormal expression of genes involved in pancreatic islet development and metabolism. Diabetes 50:2472-2480; 2001.
24. Sielaff, T. D.; Hu, M. Y.; Amiot, B.; Rollins, M. D.; Rao, S.; McGuire, B.; Bloomer, J. R.; Hu, W. S.; Cerra, F. B. Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J. Surg. Res. 59:179-184; 1995.
25. Sladek, F. M.; Zhong, W. M.; Lai, E.; Damell, J. E. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev. 4: 2353-2365; 1990.
26. Spath, G. F.; Weiss, M. C. Hepatocyte nuclear factor 4 provokes expression of epithelial marker genes, acting as a morphogen in dedifferentiated hepatoma cells. J. Cell Biol. 140:935-946; 1998.
27. Tian, J. M.; Schibler, U. Tissue-specific expression of the gene encoding hepatocyte nuclear factor 1 may involve hepatocyte nuclear factor 4. Genes Dev. 5:2225-2234; 1991.
28. Ting, P. P.; Demetriou, A. A. Clinical experience with artificial liver support systems. Can. J. Gastroenterol. 14: 79D-84D; 2000.
29. Tobe, S.; Takei, Y.; Kobayashi, K.; Akaike, T. Receptor-mediated formation of multilayer aggregates of primary cultured adult rat hepatocytes on lactose-substituted polystyrene. Biochem. Biophys. Res. Commun. 184:225-230; 1992.
30. Uchino, J.; Tsuburaya, T.; Kumagai, F.; Hase, T.; Hamada, T.; Komai, T.; Funatsu, A.; Hashimura, E.; Nakamura, K.; Kon, T. A hybrid bioartificial liver composed of multiplated hepatocyte monolayers. ASAIO Trans. 34: 972-977; 1988.
31. Vickers, C.; Neuberger, J.; Buckels, J.; McMaster, P.; Elias, E. Transplantation of the liver in adults and children with fulminant hepatic failure. J. Hepatol. 7:143-150; 1988.
32. Watanabe, F. D.; Mullon, C. J.; Hewitt, W. R.; Arkadopoulos, N.; Kahaku, E.; Eguchi, S.; Khalili, T.; Arnaout, W.; Shackleton, C. R.; Rozga, J.; Solomon, B.; Demetriou, A. A. Clinical experience with a bioartificial liver in the treatment of severe liver failure. A phase I clinical trial. Ann. Surg. 225:484-491; 1997.
33. Williams, R.; Wendon, J. Indications for orthotopic liver transplantation in fulminant liver failure. Hepatology 20: S5-S10; 1994.